GHK-Cu

GHK-Cu is a naturally occurring copper-binding tripeptide complex studied in extracellular-matrix biology, wound models, gene-expression research, skin biology, inflammation, and tissue remodeling.

GHK binds copper ions and may influence matrix metalloproteinases, collagen-related pathways, antioxidant signaling, inflammatory mediators, and gene expression in experimental systems.

Meaningful topical and preclinical literature; systemic human evidence is limited.

Level III, Limited human evidence

Evidence depends on route, formulation, copper stoichiometry, and product identity. Topical findings do not establish systemic effects.

Potential concerns include copper-related toxicity, local irritation, contamination, oxidative effects, and uncertain systemic pharmacology.

No broadly approved injectable GHK-Cu drug product; exact formulation and intended route are regulatory determinants.

Supplied strictly for in-vitro and ex-vivo laboratory research. Not for human or veterinary administration, diagnostic, or therapeutic use. Import and regulatory compliance remain the responsibility of the receiving researcher.

• GHK-Cu, 50 mgLyophilized
• GHK-Cu, 100 mgLyophilized
• GHK-Cu, 3 mg × 60Capsule

Every Cendrix lot ships with an HPLC purity chromatogram, mass-spectrometry identity confirmation, appearance and reconstitution observations, and endotoxin testing where applicable. Lot certificates are retrievable from the Quality page using the lot number printed on the vial.

External searches link to PubMed, ClinicalTrials.gov, Google Scholar, and FDA records. Cendrix does not endorse interpretations published in third-party sources.